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Imaging in Non-neurologic Oncologic
Treatment Planning of the Head and
Neck
Katherine S. Hansen* and Michael S. Kent
Department of Surgical and Radiological Sciences, UC Davis School of Veterinary Medicine, Davis, CA, United States
Imaging is critical for the diagnosis and staging of veterinary oncology patients. Although
cytology or biopsy is generally required for diagnosis, imaging characteristics inform
the likelihood of a cancer diagnosis, can result in a prioritized list of differentials
that guide further staging tests, and assist in the planning of surgery, radiation, and
chemotherapy options. Advanced imaging, such as CT and MRI, can better define the
extent of disease for surgical and radiation planning for head and neck cancer cases
in particular. Additionally, new imaging technologies are continually being translated into
veterinary fields, and they may provide more options for cancer patients as they become
more widely available.
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PATIENT STAGING
Imaging can be used to assess the extent of local disease and response to treatment, identify lymph
nodes that may have metastatic disease, screen distant organs for possible metastasis, and allow
image-guided sampling of suspected neoplastic lesions. Choosing the best imaging technique for a
patient depends on several factors including where and what is being imaged, what information is
needed, and also sometimes cost of the imaging procedure to decide on a best course of action for
an individual patient. It should be noted, however, that while imaging can be suggestive of cancer,
no imaging technique is able to diagnose cancer per se on its own, and that a histopathologic or
cytologic diagnosis is required for confirmation.
Cancer staging refers to determining the local extent of the tumor and whether or not it has
spread. While multiple staging schemes for individual tumor types in different locations have been
developed in veterinary medicine, they have not always been shown to provide prognostic value,
and in some cases multiple staging schemes have been proposed for a particular tumor type. The
concept of staging however is essential to developing a treatment plan for a particular patient,
and imaging is central to staging a patient. Generally, tumor staging follows the World Health
Organization’s recommendations, which are based on the TNM system (1). T refers to the local
tumor and relates to the size, and in some cases the invasiveness and/or the histologic grade, of
the tumor. N relates to regional and distant nodal metastasis, and M refers to other, non-nodal
metastasis of the tumor. In order to develop a rational treatment plan for a veterinary oncology
patient, it is essential to gather as much information as possible about the tumor, its biological
behavior and the patient. A biopsy when available will usually provide a histologic diagnosis and
grade which can in turn guide decision making in how to approach the individual patient.
Staging of particular tumor types by location is discussed in the disease specific sections of
this article below; there are however are some general considerations. There is a balance to be
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reached between thoroughly evaluating a patient and performing
imaging studies that are likely to be of low yield, or even perhaps
finding lesions that are not likely related and lead to unnecessary
invasive procedures.
While most clinicians would agree that a general health
screening, particularly for animals that will be anesthetized for
imaging or other procedures, including a complete blood count,
chemistry panel, and ideally urinalysis for an older animal
diagnosed with cancer is appropriate, what is included in this
screening beyond basic bloodwork is more controversial. In one
study of dogs presenting to an oncology service, approximately
3% of the 1,722 dogs during the study period were diagnosed
with multiple distinct malignancies (2). Cases diagnosed with
thyroid carcinoma, malignant melanoma and mast cell tumor
that also had at least one other type of cancer diagnosed were
found to be overrepresented in the study group. All three of
these tumor histologies can affect the head and neck. Interestingly
the study authors also found that 1/3 of the dogs presenting
with thyroid tumors were diagnosed with at least one additional
tumor. A separate study looking at dogs diagnosed with soft
tissue sarcomas, primary brain tumors, and nasal tumors that
had thoracic radiographs and abdominal ultrasound done as
part of their staging also found a 3% rate of multiple distinct
malignancies (3). A third study that retrospectively evaluated the
diagnosis of additional synchronous tumors discovered during
computed tomography (CT) scans performed for radiation
therapy planning also found an occurrence of approximately 3%
in 736 studies (4).
Regardless of tumor type or grade of a tumor, some clinicians
recommend an abdominal ultrasound of all patients prior to
proceeding with advanced imaging studies or treatment. This is
to evaluate the patient for concurrent disease and general health.
In the Marchello study mentioned above, using abdominal
ultrasound to screen dogs diagnosed with soft tissue sarcomas,
primary brain tumors, and nasal tumors, all of which are reported
to have a low metastatic rate on diagnosis, they found abnormal
abdominal ultrasound characteristics in 78, 87, and 80% of the
cases, respectively (3). In the majority of these cases the findings
were not considered to be major, and only four of these findings
in 101 cases altered the treatment plan.
More work needs to be done to evaluate the best practice with
regards to a general health screening and what that includes.
For now, offering an owner a more comprehensive work-up
than might be required for a particular tumor type is reasonable
as long as it is balanced with a discussion of cost vs. likely
benefit. These costs include not only financial considerations
but also the risk to the patients when the imaging procedure
requires anesthesia.
Imaging, particularly with CT and magnetic resonance
imaging (MRI), can also be used when evaluating the local
extent of disease to help determine if a tumor is resectable and
to help plan the surgical dose needed to attempt a complete
resection (5). CT in general is considered superior than standard
radiography in identifying tumor, underlying boney change as
well as invasion into adjacent structures (6) as noted in Figure 1
with a canine nasal carcinoma. MRI can also help delineate the
extent of tumor and whether a complete resection is possible.
The role of positron emission tomography (PET/CT) imaging
in defining the true extent of tumors is still very early in
development in veterinary medicine, although it holds promise
of helping to more accurately define tumor extent which in turn
can help surgeons plan their treatments (7). Additionally, 3-
dimensional (3D) reconstructions of CT scan images can help
surgeons assess whether surgery is a possibility for head and neck
tumors (Figure 2). 3D reconstructions also help surgeons map
locations for osteotomy and can provide opportunities for 3D-
printed prostheses (8, 9) For example, a recent study combined
CT imaging, 3D reconstruction, and a regenerative surgical bone
matrix to improve post-operative outcomes in five dogs receiving
rostral manibulectomy (10).
When evaluating head and neck tumors for locoregional
metastasis, the major regional lymph nodes to identify include
the mandibular, medial retropharyngeal, cervical, and superficial
cervical lymph nodes (11) (Figure 3). Uncommonly the facial
nodes, parotid lymph nodes and the lateral retropharyngeal
lymph nodes may be affected. It is important to evaluate all the
lymph nodes and not just the mandibular ones as over 50% of
the cases with regional nodal metastatic disease in head and neck
cancer may not involve the mandibular lymph nodes (11). CT is
commonly used to identify lymph nodes in head and neck cancer
cases. Its value in determining if there is metastasis is limited,
however. CT and ultrasound can also be used to guide aspirates
and sampling of lymph nodes to assess them for metastatic
disease. One study looking at the diagnostic accuracy of CT for
determining metastatic mandibular and medial retropharyngeal
lymph nodes in dogs with either nasal or oral cancers found
sensitivity was 12.5 and 10.5%, and the specificity was 91.1 and
96.7%, for mandibular and medial retropharyngeal lymph nodes,
respectively (12). This same study found that no CT parameter
was predictive of metastasis. In another study, 23% of enlarged
lymph nodes were identified as metastatic and 6% of normal
appearing lymph nodes on CT were aspirated and contained
metastatic disease (4). These studies highlight the importance of
sampling lymph nodes even if they appear normal on imaging.
Imaging can also be used to help identify the sentinel lymph
node (first draining lymph node) or nodes from a tumor bed. This
is ideal as it focuses the clinician to evaluate only these sentinel
nodes rather than all of the regional nodes (13). There have been
multiple studies using imaging techniques to identify sentinel
lymph nodes from primary tumors in dogs. These techniques
include CT lymphography, lymphoscintigraphy, and contrast
ultrasound (14–16). Again, these techniques are used to simply
identify the draining lymph nodes, but these lymph nodes still
must be sampled either by aspirate or biopsy to determine if there
is metastatic disease present. Novel imaging techniques such as
PET/CT are also on the horizon and have been used to identify
locoregional lymph node involvement (17).
Screening the lungs for possible metastasis is common
practice for most malignant head and neck tumors. Again,
some clinicians recommend this imaging procedure for all
patients prior to invasive procedures and as part of a general
health screen, particularly for geriatric animals regardless of
the tumor diagnosis. Three view thoracic radiographs taken at
peak inspiration are the generally accepted minimal standard
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FIGURE 1 | CT imaging provides superior assessment of bone destruction for a canine nasal carcinoma. (A) (Upper Left) and (B) (Lower Left) Oblique and lateral
images reveal a mass in the right nasal cavity and sinus, but the degree of boney involvement is not well defined. (C) (Upper Right), Transverse, (D) (Middle Right)
Sagittal, and (E) (Lower Right) Dorsal images of the same dog with non-contrast CT imaging reveals extensive, right-sided bone destruction of the hard palate (white
arrow, C), cribriform plate (white arrow, D), turbinates and orbit (white arrow, E) that is not clearly evident on the original radiographs.
for assessing the lungs for both a general health screening and
for screening for metastatic disease (18–20). The likelihood of
discovering metastatic disease is dependent on the biological
behavior of the tumor histology and grade. Although even in
tumors that are thought not to be highly metastatic, its presence
would likely change the treatment plan. Other non-neoplastic
disease can also be identified, which can justify carrying out
this imaging procedure (3). More recently CT has been used
to assess veterinary subjects for the presence of pulmonary
metastasis and has been found to be more sensitive than 3-view
thoracic radiographs in detecting pulmonary metastasis (21–
23). One of these studies suggested that pulmonary nodules of
1mm could be detected on CT while nodules had to be at least
7–9mm for detection using conventional thoracic radiographs
(23). However, because few data exist on the outcomes expected
when lung involvement is detectable on CT imaging but not
radiographs, it is not clear to what degree a lead-time or length-
time bias may play a role as more data are collected (24).
Whole body CT scans have fallen out of favor in human
medicine for cancer screening as it has not been shown to be
an effective screening method. However, whole body CT has
been effectively used for staging patients already diagnosed with
cancer. There are limited studies in veterinary medicine on using
whole body CT to screen dogs and cats with a cancer diagnosis.
Studies describing this procedure to date have been limited and
included findings of muscle metastasis in whole body CT scans
in dogs and cats and for staging of osteosarcoma (25). Fused
PET/CT has been used more commonly in human medicine for
cancer staging than whole body CT alone and is starting to be
explored in veterinary medicine.
GENERAL APPROACH TO THE
ONCOLOGIC PATIENT
Treatment Approaches: Surgery,
Chemotherapy, and Radiation
Multi-Modality Therapy
Malignant tumors require both local control and control of
possible regional or distant metastasis to achieve the best patient
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FIGURE 2 | Imaging and radiation planning for adaptive radiotherapy. (A) (Upper left) Original radiation planning CT image with PTV (red line and yellow-shaded
region) contoured for a nasal carcinoma. (B) (Upper right) Mid-way through radiation treatment the tumor decreased in size. The shrinkage caused the right eye (blue
shaded region) to fall within the original PTV (red line and yellow-shaded region). The green shaded area shows the region of the eye now overlapping with the PTV,
and is also noted with a solid arrow.
outcome. Surgery remains a mainstay of treatment for local
control for many tumors of the head and neck. Tumors that
cannot be completely resected may also be treated with radiation
in some cases. One exception to surgery as a primary option is in
the treatment of nasal tumors. Most nasal tumors, regardless of
cell of origin, are treated with radiation therapy (26).
Head and neck tumor types carrying significant metastatic
potential may also be treated with chemotherapy in addition
to surgery or radiation. For smaller canine oral melanomas,
cliniciansmay recommend primarily surgery, or surgery followed
by radiation, and also offer the option of carboplatin and/or
the melanoma vaccine after local control to help reduce the
risk of metastasis (27–29). Thyroid tumors are another example
where a combination of surgery, radiation, and chemotherapy
may be recommended depending on the expected risk for
metastasis and the surgical outcome (30, 31). There are more
data regarding outcomes for some tumors than others, and
it can be challenging to make strong recommendations for
a particular combination of treatments based on the number
of veterinary cases in the literature (26, 32). The concept of
chemoradiation has also been attempted in veterinary medicine,
wherein chemotherapy and radiotherapy are delivered together
with the intent to radiosensitize cells with a chemotherapy drug
and improve tumor control. However, radiosensitization can also
increase normal tissue toxicity and bone marrow suppression,
resulting in undesirable breaks in treatment (33).
Imaging for Radiation Planning
Modern radiation oncology is heavily reliant on imaging for
treatment planning. Radiation oncologists will identify and map
out target volumes and critical normal structures with the idea
of maximizing dose to the tumor and minimizing dose to the
surrounding normal structures. The three main tumor target
volumes that are used for prescribing a dose are the gross
tumor volume (GTV), the clinical tumor volume (CTV) and
the planning target volume (PTV). The GTV is the defined as
the visible tumor on visual inspection or imaging. The CTV
comprises the GTV with the addition of a margin, dependent
on the tumor type, to account for subclinical and microscopic
spread of the tumor into surrounding tissues, and the PTV
is an additional margin that is added to the CTV to account
for errors in positioning, patient motion during treatment, and
machine and imaging alignment on the therapy unit. With
the advent of image guidance with electronic portal imaging,
and linear accelerators with built-in Cone Beam Computed
Tomography (CBCT) or other 3-dimensional imaging, the PTV
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FIGURE 3 | Axial CT imaging of metastatic neck lymph nodes associated with
canine oral tumors. (A) (Top) Melanoma metastasis was detected in the
enlarged, contrast enhancing, left mandibular lymph node (solid arrow) on CT
imaging. (B) (Bottom) Metastatic melanoma cells from an oral mass were
found in the enlarged, heterogeneously contrast enhancing, right
retropharyngeal lymph node (solid arrow) on CT imaging.
can be reduced, but not generally eliminated, allowing for
improved conformality of dose. Determination of an individual
patient’s GTV and CTV, while fairly straight forward to define
in concept, can in actuality be difficult to delineate and
contour on imaging sets (34). Functional imaging such as
PET/CT scanning may allow better delineation of the GTV and
possibly CTV, although its use in veterinary medicine remains
largely unexplored (7).
CT scans are specially adapted for radiation planning.
Although many human patient facilities have a dedicated CT
scanner for so-called radiation planning “simulation CT” scans
(35), veterinary hospitals often have removable, flat couch-tops
that can be utilized on the hospital CT scanner that is otherwise
used for diagnostic CT imaging cases (36, 37). Duplicating
the setup used for the CT simulation of radiation planning
is critical for 3D radiation treatments. Thermoplastic masks,
vacuum-locked moldable bags, dental molds for bite blocks, and
nonmigrating fiducially imbedded in tumors aid in replicating
FIGURE 4 | Canine patient with head and neck positioning device. An
anesthetized canine patient is placed in a positioning frame with pillow and
thermoplastic mask used for head and neck radiation patients.
the positioning of the patient and the PTV for subsequent
treatments (38–46) (Figure 4).
The field of view of a CT scan for radiation planning is
generally much larger than that routinely used for diagnostic
imaging. As such, there are limitations as to how large of a
patient can be treated based on the bore size of the CT scanner
(47, 48). Additionally, the larger field of view results in lower
resolution of the image, especially in small patients with large
fields of view that may include the shoulders for small head and
neck lesions (49). The slice thickness and subsequent volume
averaging that occurs across the individual CT image can lead
to over- or underestimation of a gross tumor margin with loss of
spatial resolution as well. This may require that additional scans
with small fields of view and relatively thin slice thickness are
performed and then subsequently fused to the calculation CT to
have better tumor delineation.
Once images are acquired, they are imported into treatment
planning software. In general, the CT images from which the
radiation therapy treatment planner calculates should come from
a non-contrast CT scan. As iodinated contrast agents are present
at the time of imaging, but not when a patient is receiving
radiation treatment, there is some concern that the additional
attenuation seen on the contrast CT images could lead to dose
calculation inaccuracies. This would be of particular concern near
organs with a substantial amount of contrast uptake. In areas
without a lot of contrast uptake by the local tissues, the dose
calculated for a post-contrast CT image set is unlikely to vary
by more than 1% compared to a calculation performed for a
pre-contrast CT image set (50).
SELECTED TUMOR TYPES AND THE ROLE
OF IMAGING IN DIAGNOSIS
AND TREATMENT
Oral Tumors
The most common non-odontogenic oral tumors seen in
veterinary patients include oral melanoma, squamous cell
carcinoma, and sarcomas. The most common odontogenic oral
tumors seen in veterinary patients include those formerly called
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FIGURE 5 | Axial CT imaging of primary head and neck tumors. (A) (Upper
left) Non-contrast CT imaging with bone window/leveling reveals extensive
bony lysis in one mandible from an oral melanoma. (B) (Upper right) Contrast
CT imaging of the same case reveals a heterogeneously contrast enhancing
mass that extends medially into the soft tissues near the affected mandible. (C)
(Lower left) Contrast CT imaging reveals cribriform lysis (red circle) and invasion
into the cranial vault of a contrast enhancing nasal carcinoma. (D) (Lower right)
A large, contrast enhancing, carotid body tumor infiltrates into the surrounding
soft tissues (dashed red line) and extends to the spinal cord (solid arrow).
epulides, now referred to as acanthomatous ameloblastomas and
peripheral odontogenic fibromas.
CT can provide anatomic information and 3D-spatial
information for oral tumors that is superior to radiography. CT
is often necessary to define the extent of more caudally located
tumors for surgery and radiation planning, and CT can better
define regional lymph nodes in terms of size when compared
to ultrasound (51). Both CT and MRI may be important for
assessing the extent of disease and potential bone involvement,
improving the chance of a complete excision and better outcome
(6, 52) (Figures 5A,B). Recently, a study on oral tumors in dogs
showed that while MRI and CT showed similar findings for
bony changes, CT was better for visualizing calcification and
cortical bone destruction, whileMRI was better to evaluate tumor
size and invasion of adjacent soft tissue structures (53). When
comparing conventional radiography and CT, the cross-sectional
imaging of CT avoids superimposition of tissues, and in one
study of 21 dogs, bony changes were detected more commonly
on CT when compared to radiographs (95.2 vs. 80.9%). Invasion
into neighboring structures was also much more readily detected
with CT (90.4 vs. 30%) in the same study. Additionally, it is
reported that bone lysis is not evident on plane films until 40%
or more of the cortex is destroyed (54).Therefore, CT appears to
be critical for surgical and/or radiation therapy planning for oral
cancers (6).
Additionally, regional lymph nodes and their contrast uptake
can be assessed with advanced imaging; however, in a recent
study the sensitivity of CT for detecting mandibular and
medial retropharyngeal lymph nodes metastasis was low (10.5–
12.5%), specificity was high (91.1–96.7%), and accuracy was
modest (67.5–76.3), suggesting that relying on CT imaging alone
for lymph node diagnosis is insufficient (12). Moreover, the
metastatic pattern of oral tumors can be variable: for example,
40% of dogs with normal-size lymph nodes had melanoma
metastasis (55), and only 55% of oral cancer patients with
metastasis to a regional lymph node having metastasis to the
mandibular lymph node (11).
Canine
Oral cavity tumors are the 4th most common cancer in
dogs (56). Canine oral tumors are generally locally invasive
and the chance of metastasis depends on the histology, with
some canine squamous cell carcinomas and most oral canine
malignant melanomas spreading to locoregional lymph nodes
and the lungs (56).
Melanoma
Melanoma is most common oral cancer in dogs, and is seen on
the gingiva, lips, tongue, and hard palate (56). Oral melanoma
behaves more aggressively than its haired skin counterpart, and
size and stage inform survival in these patients (57, 58). Because
melanoma is highlymetastatic and also locally invasive, including
into bone, CT imaging can be highly valuable for surgical and/or
radiation planning.
Squamous cell carcinoma
Squamous cell carcinoma (SCC) is the secondmost common oral
tumor in the dog (59). SCC can also invade into bone, and as
such CT imaging is helpful in defining the extent of disease. Non-
tonsillar SCC in dogs appears to have a modest metastatic rate of
approximately 20% (60).
Sarcoma
Fibrosarcomas are the third most common oral malignancy
in the dog, and often occur in large breed dogs. As a group,
they are locally invasive but with a moderate lung metastatic
rate of <30% (60, 61). A specific subtype of fibrosarcomas
referred to as histologically low-grade but biologically high grade,
have a remarkably benign appearance on histology similar to
fibromas, but can be rapidly growing and readily invade into
bone (62). Advanced imaging with CT can be critical to plan for
appropriate surgical margins, provide realistic expectations for
surgical cure, and prepare for radiation planning of these oral
fibrosarcomas (61).
Epulides
Epulides are considered benign masses, and they include
acanthomatous ameloblastomas (previously known as
acanthomatous epulis) and peripheral odontogenic fibromas
(previously known as ossifying and fibromatous epulides) (63).
Acanthomatous ameloblastoma has the unique feature among
epulides of frequently invading into underlying bone. This bony
invasion can be better defined by CT imaging to prepare for
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larger resections and/or radiation fields required for this tumor
type compare to other epulides (64, 65).
Feline
Oral cavity tumors comprise approximately 3% of all cancers
in the cat, with, squamous cell carcinoma being the most
common oral malignancy. SCC in cats may invade extensively
into bone in cats such that CT imaging is of great benefit
(66). Metastatic frequency is not completely defined because
local control is uncommon, resulting in euthanasia due to the
primary tumor after a short period of time in many cases (67).
Fibrosarcomas are the second most common tumor in the cat
(56), but comprise <20% of feline oral tumors (68). Metastasis is
relatively uncommon, and treatment involves primarily surgery
or radiation. Epulides are uncommon in cats, with a clinical
presentation of multiple epulides being noted, particularly in
young cats (69).
Intranasal
CT provides precise anatomic information that is superior to
radiography for both oral and nasal tumors when compared to
radiographs (70). A staging system has been developed based on
CT imaging as well, where the integrity of the cribriform plate
may be associated with outcome (71) (Figure 5C), but several
other staging systems have also been proposed.
On MRI and CT, bony destruction, sphenoid sinus
destruction, retrobulbar space involvement, nasopharyngeal
involvement, lateral maxillary hyperostosis, and patchy increased
density within abnormal soft tissues are associated with, but not
definitive for, nasal cancer (72, 73). Importantly, a mass in the
nasal cavity is not specific for nasal neoplasia (72). While CT is
most commonly used for imaging the nasal cavity when staging
nasal tumors, there have been two studies comparing their utility
to MRI. In one study, comparison of MRI and CT revealed that
MRI is only more helpful in defining the portions of tumors
that extend into the cranial vault (74). In another more recent
pilot study evaluating the utility of each imaging modality for
the staging of nasal tumors, there was a high level of agreement
when assessing bone involvement. However, MRI revealed a
higher tumor volume in five out of six cases and was also better
at detecting meningeal enhancement than CT (75). Regarding
radiographs of the nasal cavity, similar to advanced imaging, they
must also be obtained with the patient under general anesthesia
to allow for precise positioning needed to obtain a diagnostic
study (76). Radiographs are only similarly sensitive to CT for
detecting changes associated with nasal tumors in cases that
present with clinical signs (77). However, they are of limited use
in determining the extent of disease.
Canine
Nasal tumors are more common in dogs than in cats, and
carcinomas (comprising approximately 2/3 of cases) are more
common than sarcomas in dogs, with nasal lymphoma being
rare in canines (78). Nasal tumors are locally invasive, and
extension into the brain may occur in advanced cases. Although
patients are usually euthanized due to signs related to the primary
mass, metastasis has been noted in up to 50% of cases at the
time of death, most commonly to the draining lymph nodes
and to the lungs (56).
CT is useful for staging of cases although the staging systems
remain controversial. The Adams staging system with stage 4
(cribriform plate involvement) correlates with outcome (71).
However, recent studies using stereotactic radiation for cases with
cribriform involvement did not associate this CT finding with
outcome (79). CT can also be used to assess for response to
treatment and recurrence, as evidenced by 46% of cases having
marked tumor regression in one study (80) and approximately
86% in another study (81).
Feline
Lymphoma is the most common nasal tumor of the cat (56).
Carcinomas, including SCC are the next most common category,
with sarcomas and other tumors less commonly reported (82, 83).
CTmay reveal paranasal bone osteolysis, extension into the orbit,
a space-occupying mass, or turbinate destruction that may be
more common with neoplasia (84), but ultimately severe rhinitis
can result in similar signs. Another study suggested that feline
intranasal neoplasia was more likely in cases with unilateral lysis
of the turbinates, lysis of a variety of bones including the dorsal
and lateral maxilla, vomer bone, and ventral maxilla, and soft
tissue or fluid in the sphenoid recess, frontal sinus, or retrobulbar
space (85). Evaluation of the cribriform plate for extension
of tumor into brain may also be prognostic (86). Finally,
several institutions are exploring both bland embolization and
chemoembolization procedures using CT guidance for nasal
tumors in dogs and cats, with one successful treatment reported
in a cat with adenocarcinoma (87).
Ear Canal
Canine
Ceruminous gland tumors (both benign and malignant) are
the most common type arising from the ear canal, with SCC,
undifferentiated carcinomas, and several other tumor types being
reported in the literature as well. There are conflicting data
as to whether benign vs. malignant ceruminous gland tumors
are more common in the dog, which cannot be differentiated
on advanced imaging (88, 89). Because a significant subset of
canine ear canal tumors are ceruminous gland adenocarcinomas
that can metastasize eventually and are also locally invasive
(for example 13/27 dogs in one study had bulla lysis on CT),
CT is recommended for surgical planning and assessment for
locoregional disease (88). Additionally, bilateral cancer has been
reported in the dog (90). CT scans can also be used for
radiation planning (91).
Feline
Inflammatory polyps are seen commonly in cats, with benign
ceruminous gland adenomas also reported in multiple cases
(88). Ceruminous gland adenocarcinomas are the most common
malignant ear canal tumor in the cat, and are more common
than their benign counterpart (89). Additionally, cats can develop
SCC that can be highly invasive into bone and surrounding
tissue (88). Because a significant subset of feline ear canal tumors
is either ceruminous gland adenocarcinoma or SCC that can
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metastasize and are locally invasive, CT is recommended for
surgical planning and assessment for locoregional disease.
Skull
Canine
Osteosarcoma
Axial osteosarcomas are less common than appendicular
locations; they comprise only about one-quarter of all cases
and have a lower metastatic rate than appendicular tumors
(92). Unlike appendicular tumors where amputation is often
an option, local tumor control remains a major hurdle with
axial tumors, even with modern surgical options. Complete
surgical margins are important for overall prognosis, with
one study not reaching a median disease free interval (DFI)
even with 1,503 days of follow up after complete excisions
of skull osteosarcomas (93). In another study where patients
were treated with a combination of radiation, surgery, and/or
chemotherapy, the cause of death was tumor recurrence in more
than half of cases (94).
Based on information on appendicular osteosarcoma
tumor imaging, MRI images overestimated the intramedullary
extent of osteosarcomas compared to gross and histologic
disease by only 3%, with T1-W non-contrast images being
sufficient in most cases. In comparison, lateromedial and
craniocaudal radiographs overestimated tumor length by 17 and
4 %, respectively. Scintigraphy and CT overestimated tumor
margins by 14 and 27%, respectively (95). In another study,
radiography was more accurate than nuclear scintigraphy at
measuring the extent of distal radius osteosarcomas, as nuclear
scintigraphy overestimates tumor length (96). Importantly,
CT appears to provide overall more accurate extent of
disease, with good correlation between histopathology and
imaging of intramedullary/endosteal abnormalities with a mean
overestimation of 1.8% (SD = 15%). The length of abnormal
contrast enhancement had a mean overestimation of 9.6%
(97). Radiography may underestimate tumor extent more often
than advanced imaging techniques (98). Together these data
indicate that CT may be the best imaging modality to assess bone
involvement for surgical planning.
Multilobular tumor of bone
This uncommon tumor type can arise from various locations
on the skull, including both the mandible and maxilla,
hard palate, orbit, nasal cavity and calvarium (99). These
tumors have a characteristic, but not necessarily pathognmonic,
CT imaging feature of a “popcorn” appearance defined by
rounded, well-defined lesions with either fine or coarse granular,
nonhomogeneous bone (100). MRI can also be beneficial for
those tumors abutting CNS tissues, and the tumors have mixed
signal intensities with significant areas of contrast enhancement
on post-contrast T1-W images, and the extent of brain and soft
tissue involvement is well-delineated for surgical planning (101).
The recurrence rate for these tumors after surgery is relatively
high and worse for high grade tumors (78% recurrence for
Grade III), with moderate metastatic spread most commonly
to the lung (99).
Neck
Canine
Thyroid carcinoma
Thyroid tumors are relatively uncommon, with carcinomas
being the most common type in the dog (102). In contrast,
adenomatous hyperplasia is more common in the cat (103).
In dogs, carcinomas are locally invasive and can spread via
both lymphatic and hematogenous routes; therefore, metastatic
disease is commonly seen in the regional lymph nodes, lungs, and
occasionally other locations (30, 104).
Ectopic thyroid tissue is commonly reported; it can be
found from the base of tongue to the base of the heart (30,
105). Scintigraphy results in concentration of sodium 99mTc
pertechnetate in regions of functional thyroid tissue, which
can be helpful to identify ectopic thyroid tissue and metastatic
disease, and this imaging technique is variably used for I-
131 dosing in cats and dogs with functional thyroid masses
(56). Scintigraphy may reveal heterogeneous or multinodular
regions in feline carcinomas, which are uncommon tumors,
but ultimately these scintigraphic findings are not specific to
malignant thyroid disease (106, 107).
Ultrasound is more commonly available and is routinely used
to assess thyroid masses in dogs. Fine-needle aspirate, when
attempted, may benefit from ultrasound guidance for diagnosis.
Neck lymph nodes can also be assessed with ultrasound (76).
Ultimately, CT and MRI have been shown to more reliably
identify margins of thyroid tumors in dogs for pre-operative
planning (108) and CT can be used to plan for radiation therapy.
Tonsillar and pharyngeal tumors
Pharynx In a study with 25 pathologically confirmed pharyngeal
neoplasias, including sarcomas, carcinomas, melanomas, and
one lymphoma, CT features could not be used to predict
pharyngeal tumor type in dogs, but were helpful for assessing
mass extension, lymph node involvement, and distant metastatic
spread (109), which would allow for either surgical or
radiotherapy treatment planning.
Tonsillars Squamous cell carcinoma is the most common
tonsillar cancer and is highly metastatic, with melanoma and
lymphoma being the next most common. CT features from
14 dogs with cytology or histology diagnosis, was able to
differentiate neoplastic from non-neoplastic tonsillar diseases.
Regional lymph node CT features were useful for diagnosis
in some cases, because nodes >18mm, heterogeneous contrast
and loss of the hypoattenuating hilus in medial retropharyngeal
lymph nodes were common in tonsillar neoplasia. However,
several dogs had little or no enlargement of the tonsil despite
associated metastatic lymph node involvement (110).
Carotid body tumors The carotid body is a specialized organ that
acts as a chemoreceptor, and tumors of the carotid body are
uniquely located at the bifurcation of the common carotid artery.
Brachycephalic breeds may have predisposition for forming this
type of tumor (111). This tumor type can be confused with
thyroid carcinomas on physical exam and imaging, but CT and
MRI may be beneficial in differentiating this neck neoplasm, as
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most appear as a large mass centered at the carotid bifurcation
with variable margination (Figure 5D). For both CT and MRI,
carotid body masses are strongly and heterogeneously contrast
enhancing. Interestingly, the basilar portion of the skull can
be affected with this tumor type as well (112), and although
the metastatic rate is relatively low, the tumor can spread to
multiple sites (113).
Feline
Thyroid tumors
Multinodular adenomatous hyperplasia is the most common
cause of hyperthyroidism in cats, while carcinomas comprise
approximately 1-3% of hyperthyroid cases (114). Carcinomas
are more locally invasive and are reported to metastasize in the
majority of cases to the lymph nodes and/or lung (115). Tc-
pertechnetate scintigraphy can be used to evaluate the extent
of functional thyroid tissue for diagnosis and for planning for
surgery, I-131 treatment, or external beam radiation. It is also
helpful for identifying ectopic thyroid tissue and metastatic
thyroid carcinoma tissue (107). Ultrasound is also useful to
guide percutaneous ethanol injection for treatment of solitary
adenomas in cats (116).
Tonsillar tumors
Cases of feline tonsillar tumors, most commonly squamous cell
carcinoma, are not fully characterized in the literature, although
cases are reported alongside oral squamous cell carcinoma cases
in several studies with variable outcomes (117–119). This disease
has the potential to spread to lymph nodes in a similar manner
to dogs (56). Similar to dogs, advanced imaging with CT may
benefit for assessment in surgical planning and identification
of abnormal lymph nodes; however, cytology is still critical for
lymph node assessment (120).
WHAT’S ON THE HORIZON FOR
ONCOLOGIC IMAGING?
New imaging technologies are continually being translated
into veterinary medicine. CT and MRI are now more widely
available in private practice, and PET/CT is increasingly
available in academic settings. Moreover, specialized MRI
imaging and advanced image registration software are paving
the way for adaptive radiation planning and for assessment of
treatment response.
PET-CT
PET images can be used to diagnose and stage cancer.
PET utilized tracers such as 2-deoxy-2-18F-fluorodeoxyglucose
(FDG) which can detect areas of increased sugar metabolism, or
other markers associated with tumor activity. FDG-PET is very
sensitive for regions of high metabolic activity, and consequently
PET is more sensitive for metastatic lesion detection than other
modalities (7). However, highly metabolically active regions are
not specific to cancer, and these active regions can represent
areas of inflammation. Therefore, cytologic or histopathologic
diagnosis is still needed even when PET is utilized. PET images
are created by use of radiopharmaceuticals that emit positrons.
These positron particles travel a very short distance before
encountering an electron, and this encounter results in two
photons that travel in opposite directions from each other. The
PET scanner can register these photons from which it can then
create an image based on the origin of the photons (7).
PET/CT systems are now commonplace in human medicine,
and in these systems the PET image and CT image are acquired at
a single imaging session with the resultant images superimposed.
Therefore, combined PET/CT units provide the sensitivity of
PET to detect tumors with the anatomic detail of a CT scan.
These systems also eliminate error associated with manual
fusion of PET and CT images when done by a technologist
or clinician. PET imaging combined with CT is a rapidly
advancing field in veterinary medicine, although only a few
institutions provide this imaging modality to date (7, 17, 121–
125). PET/CT can be useful for finding the extent of disease with
greater sensitivity than contrast CT in veterinary patients. For
example, a recent report showed that cats with oral squamous
cell carcinoma had more extensive soft tissue infiltration, with
FDG-PET detecting areas of possible primary tumor that were
not seen on contrast-enhanced CT scans (124). PET/CT is also
used to target molecules relevant to tumor staging. For example,
lesions consistent with disseminated hemangiosarcoma based on
PET/CT were seen in 2/9 dogs, and these lesions had not been
detected by radiography and ultrasonography (17). PET/CT may
be useful to identify tumors, or regions of tumors, that may
be more resistant to therapy. One group of investigators has
shown changes in hypoxia PET markers in untreated tumors and
in tumors undergoing radiation treatment (122, 123). However,
PET has limitations, and highly metabolic areas that may be
highlighted by FDG-PET are not specific for cancer because they
may represent inflammation (7).
DCE-MRI
Dynamic contrast-enhanced MRI (DCE-MRI) has recently been
investigated in animals. It can be used for assessment of
tumor perfusion in soft tissue sarcomas and brain tumors, and
to follow tumor responses after hyperthermia and radiation
therapy in animals (126).
Image Registration for Radiation Treatment
What Is Image Registration?
Image registration involves alignment images from different data
sets, for example images from CT, MRI and PET, or image sets
from CT before and after treatment (127).
How Is Image Registration Used in
Cancer Management?
Images acquired from CT and MRI are used throughout
the radiation planning process, as previously described, from
defining contours to verification of positioning for delivery of
daily treatments (127, 128). In some cases, MRI, CT, or PET/CT
images must be registered to each other so that they overlap for
radiation planning, in order to better define targets or organs at
risk in the radiation field. There are two types of registrations:
rigid registrations where translations and rotations of structures
that stay in spatial alignment to one another are matched, and
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FIGURE 6 | Imaging and radiation planning for adaptive radiotherapy. (A)
(Upper left) Original radiation planning CT image with PTV (red line) contoured
for a nasal carcinoma. (B) (Upper right) Mid-way through radiation treatment
the tumor decreased in size. The shrinkage caused the right eye (blue shaded
region) to fall within the original PTV (red shaded region). The purple shaded
area shows the region of the eye now overlapping with the PTV, and is also
noted with a solid arrow. (C) (Lower left) The original radiation planning heat
map reveals regions of high dose (red/orange) and regions of moderate dose
(yellow/green). The right eye (green circle) is originally planned to abut these
dose regions. (D) (Lower right) A new “adaptive” radiation plan has been
created to target the smaller, mid-treatment PTV. The right eye (green circle), is
not only outside the PTV region, it is now farther away from the high dose
(red/orange) and moderate dose (yellow/green) regions of the treatment field.
deformable registrations where some degree of tissue motion can
be matched between images. There are limitations to registration
of images sets that have been reviewed elsewhere, and rigid
registrations are generally limited to the head (127). Therefore,
there may be some degree of organ motion even in the head
and neck that must be accounted for in radiation planning
simply based on the images being used (129). As defined above,
target volumes contoured by radiation oncologists further take
uncertainties about target extent and mobility into account in the
volumes to be treated.
Registered images can also be used after treatments to
confirm that the delivered dose is similar to the planned
radiation dose. Recently, dose verification software that detects
exit dose was assessed on a veterinary radiation system. This
software relies on both proper registration of images used for
treatment planning and proper registration of on-board images
for treatment fractions (130).
Image-guided radiotherapy (IGRT), can generally refer to
using imaging to aid in radiation delivery. However, the term
IGRT may specifically reference images used to aid in target
contouring, especially when changes in the patient body (e.g.,
weight loss) or changes in the tumor (e.g., growth or regression)
necessitate a modification to the radiation treatment plan. This
type of IGRT is also known as adaptive radiation therapy
(ART) (127). Adaptive radiation ultimately involves assessment
of images during treatment, then registration of pre-treatment
and during-treatment images to create a new “adapted” radiation
plan as the contour of the patient or tumor changes during a
course of radiation therapy (Figures 6A–D).
Because anatomy does not move spatially in a rigid manner
(i.e., body parts and organs canmove independent of one another
based on patient position and normal tissue movements), there
is limited use to rigid registrations for sites other than the
head (127). Although not well described in veterinary medicine,
deformable registrations can better help create efficient ART
plans in the future (131).
MRI-Based Radiation Planning
MRI is currently used, generally via rigid registration, to help
with radiation contouring at many institutions (37, 132). MRI
has superior soft-tissue contrast which is desirable for creating
contours of normal tissues and tumors. There is interest in MRI
systems that use 70 cm bores with a flat couch similar to those
used for radiation treatment for treatment planning purposes.
MR-simulators that no longer require a CT for planning are
also highly desirable to simplify the radiation treatment planning
process and limit CT radiation exposure. MRmay also have a role
for in-room positioning and target verification devices at the time
of daily radiation treatments (rather than the currently popular
CBCT), and this use of MRI would further limit the radiation
dose associated with repeated CT imaging for patient treatment
positioning (133).
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